Monosodium Urate Crystals Trigger Nrf2- and Heme Oxygenase-1-dependent Inflammation in THP-1 Cells
Overview
Affiliations
Gouty arthritis is an inflammatory disease that is caused by an accumulation of monosodium urate (MSU) crystals in the joints. MSU is capable of activating the nucleotide-binding oligomerization domain-like receptor pyrin domain containing 3 (NLRP3) inflammasome, leading to interleukin-1β (IL-1β) secretion. Reactive oxygen species (ROS) are major mediators of the NLRP3/IL-1β interaction. Although nuclear factor E2-related factor 2 (Nrf2) is recognized as a transcription factor that is involved in the response to oxidative stress, the effect of MSU on Nrf2 and on Nrf2-mediated antioxidant enzymes remains unclear. The treatment of THP-1 monocytes using phorbol 12-myristate 13-acetate (PMA) was shown to initiate inflammatory responses. Here, we showed that THP-1 cells, following treatment with MSU crystals, significantly increased IL-1β release, NLRP3 inflammasome activation and ROS production. MSU also promoted the nuclear translocation of Nrf2 and activated lysosomal destabilization. Moreover, the levels of heme oxygenase-1 (HO-1) in gene and protein expressions were upregulated by MSU. MSU-induced IL-1β secretion and NLRP3 inflammasome activation were inhibited by the knockdown of Nrf2 and via the HO-1 inhibitor zinc (II) protoporphyrin IX (ZnPP). In addition, HO-1 inhibition increased the level of superoxide anion production and the consumption of glutathione. These findings suggest that Nrf2 and HO-1 mediate redox homeostasis and interact with pro-inflammatory factors in MSU-challenged THP-1 cells, thereby providing new insight into how MSU-induced gouty inflammation is mediated by specific mechanisms that are involved in the Nrf2/Ho-1 antioxidant signaling pathway.Cellular & Molecular Immunology advance online publication, 11 August 2014; doi:10.1038/cmi.2014.65.
Exploring NLRP3-related phenotypic fingerprints in human macrophages using Cell Painting assay.
Herring M, Sarndahl E, Kotlyar O, Scherbak N, Engwall M, Karlsson R iScience. 2025; 28(3):111961.
PMID: 40040812 PMC: 11876907. DOI: 10.1016/j.isci.2025.111961.
Homotherapy for heteropathy: therapeutic effect of Butein in NLRP3-driven diseases.
Liao W, Li Y, Liu J, Mou Y, Zhao M, Liu J Cell Commun Signal. 2024; 22(1):315.
PMID: 38849890 PMC: 11158000. DOI: 10.1186/s12964-024-01695-7.
Identification of potential biomarkers of gout through weighted gene correlation network analysis.
Wang X, Yang B, Xiong T, Qiu Y, Qin Y, Liang X Front Immunol. 2024; 15:1367019.
PMID: 38686389 PMC: 11056514. DOI: 10.3389/fimmu.2024.1367019.
Mitochondrial Cation Signalling in the Control of Inflammatory Processes.
Pain P, Spinelli F, Gherardi G Int J Mol Sci. 2023; 24(23).
PMID: 38069047 PMC: 10706693. DOI: 10.3390/ijms242316724.
The NLRP3 inflammasome: role in the pathobiology of chronic pain.
Chen C, Smith M Inflammopharmacology. 2023; 31(4):1589-1603.
PMID: 37106238 PMC: 10352419. DOI: 10.1007/s10787-023-01235-8.